This breakthrough coronavirus vaccine already worked on monkeys

$%name This breakthrough coronavirus vaccine already worked on monkeys by Authcom, Nova Scotia\s Internet and Computing Solutions Provider in Kentville, Annapolis Valley$

The ChAdOx1 nCoV-19 coronavirus vaccine candidate developed by Oxford scientists is already in Phase 1 human trials and could be ready for emergency use as soon as September, a previous report said.
The researchers have published a first study detailing their research on mice and monkeys, and the data suggests the COVID-19 vaccine can stop the virus from replicating inside the body.
Visit BGR’s homepage for more stories.

The novel coronavirus is here to stay, WHO officials said earlier this week. Before that, Dr. Anthony Fauci said it’s not likely for the virus to be eradicated anytime soon or even at all. That may have sounded like bad news, but it really isn’t. We’ve already reached a point where we have several viable COVID-19 therapies that can reduce the time it takes to recover and prevent complications, and they’ll be further perfected in the months to come. Moreover, an increasing number of companies are developing lab-made antibodies that can replicate the success of plasma transfusions from COVID-19 survivors to defeat the virus. And the first vaccine candidates that are effective and safe might be approved for emergency use as soon as this fall.

More than 115 teams were working on vaccine candidates as of mid-April, and several of them have started clinical trials. The results are already coming in for some of them, and the promising Oxford drug that could be ready by September just delivered more good news: ChAdOx1 nCoV-19 works on monkeys.

Continue reading…

Today’s Top Deals

Trending Right Now:

This breakthrough coronavirus vaccine already worked on monkeys originally appeared on BGR.com on Sun, 17 May 2020 at 13:46:44 EDT. Please see our terms for use of feeds.